ACTR Trademark

Trademark Overview

On Wednesday, October 18, 2017, a trademark application was filed for ACTR with the United States Patent and Trademark Office. The USPTO has given the ACTR trademark a serial number of 87649971. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 7, 2025. This trademark is owned by Unum Therapeutics Inc.. The ACTR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer

General Information

Serial Number87649971
Word MarkACTR
Filing DateWednesday, October 18, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 7, 2025
Registration Number5547431
Registration DateTuesday, August 21, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2018

Trademark Statements

Pseudo MarkANTIBODY COUPLED T-CELL RECEPTOR
Goods and ServicesPharmaceutical products for the prevention and treatment of cancer
Pseudo MarkACTOR

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 7, 2025
Primary Code005
First Use Anywhere DateTuesday, October 31, 2017
First Use In Commerce DateTuesday, October 31, 2017

Trademark Owner History

Party NameUnum Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameUnum Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameUnum Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Monday, January 22, 2018EXAMINERS AMENDMENT -WRITTEN
Saturday, October 21, 2017NEW APPLICATION ENTERED
Friday, October 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 17, 2018ASSIGNED TO EXAMINER
Monday, January 22, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 22, 2018EXAMINERS AMENDMENT E-MAILED
Monday, January 22, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, January 31, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 30, 2018USE AMENDMENT FILED
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 30, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, July 18, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 20, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 20, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 20, 2018SU - NON-FINAL ACTION - WRITTEN
Wednesday, June 20, 2018NON-FINAL ACTION E-MAILED
Wednesday, June 20, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 13, 2018ASSIGNED TO LIE
Tuesday, July 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 19, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 21, 2018REGISTERED-PRINCIPAL REGISTER
Monday, August 21, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 7, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

actr cancer treatment prevention products pharmaceutical